Skip to main content
Premium Trial:

Request an Annual Quote

Making the Transfer

It's been nearly 30 years since the Bayh-Dole Act allowed universities to gain IP and National Academy of Sciences looks into the effectiveness of the technology transfer system and whether it's had any unintended effects. It finds that universities should temper their expectations of technology transfer. "Patenting and licensing practices should not be predicated on the goal of raising significant revenue for the institution," the report says. "The likelihood of success is small, the probability of disappointed expectations high, and the risk of distorting and narrowing dissemination efforts is great." The academy also suggests that universities draw on their knowledgeable staff, both faculty members and business people, to help in the operations and oversight of the tech transfer offices, adds the Chronicle of Higher Education.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.